Veracyte Inc. Revenue 2011–2025
Veracyte Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Veracyte Inc. revenue for the quarter ending March 31, 2026 was 139.1 M, a 21.49% increase year-over-year.
- Veracyte Inc. revenue for the twelve months ending March 31, 2026 was 515.6 M, a 23.57% increase year-over-year.
- Veracyte Inc. annual revenue for 2025 was 517.1 M, a 16.01% increase from 2024.
- Veracyte Inc. annual revenue for 2024 was 445.8 M, a 23.46% increase from 2023.
- Veracyte Inc. annual revenue for 2023 was 361.1 M, a 21.76% increase from 2022.
- Veracyte Inc. annual revenue for 2022 was 296.5 M.
Veracyte Inc. (VCYT) — Frequently Asked Questions
Veracyte Inc. (VCYT) is a publicly traded US company. It has a market capitalization of $3.80B. In fiscal 2025 it reported revenue of $517M and net income of $66M. Explore VCYT's stock price, financial statements, earnings history, margins and key ratios below.
What is Veracyte Inc.'s market cap?
Veracyte Inc. (VCYT) has a market capitalization of $3.80B.
What is the VCYT stock price?
VCYT trades at $47.19 (-2.03% on the day).
How much revenue does Veracyte Inc. make?
Veracyte Inc. reported revenue of $517M in fiscal 2025.
Is VCYT profitable?
In fiscal 2025, Veracyte Inc. reported net income of $66M.